ArticleCureus2019

Positive Response and Increase in ADAMTS13 with Scheduled Rituximab in a Patient with Relapsing Thrombotic Thrombocytopenic Purpura.

Bahaa Amer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.